PALO ALTO, Calif. and
PHILADELPHIA, Sept. 13, 2019 /PRNewswire/ -- Varian (NYSE:
VAR) today announced it is investing in Oncora Medical and
partnering to accelerate the development of software tools to
enable precision medicine in radiation oncology. Oncora is a
privately-held digital health company using software and data to
equip doctors and scientists with analytics tools to develop the
optimal cancer treatment plan for each patient.
Oncora Patient Care™, the company's documentation, workflow, and
decision support solution, was developed in conjunction with
oncologists at MD Anderson Cancer Center and helps capture critical
data about cancer patients, their treatments, and their clinical
outcomes so that doctors can learn from past experience to improve
care for patients.
Oncora's predictive modeling engine encodes this knowledge in
computational models that can accurately predict the outcomes of
new patients' treatments. Varian and Oncora plan to use these
predictive models to help doctors design treatments for patients
that minimize their risk of toxicity and maximize their chance for
cure. Oncora Analytics™, the company's research engine, aggregates
longitudinal data on prior patients and makes this real-world data
available to power scientific and medical research. The software is
in use at 13 sites of care across the
United States.
"We envision a world where all patients have access to the
highest quality cancer care regardless of their location," said
Corey Zankowski, senior vice
president of Varian Oncology Software Solutions. "Oncora Medical's
ability to aggregate vast amounts of patient data is designed to
empower oncologists with a decision support tool to achieve the
goal of elevating the standard of care across the country."
"Oncora's mission is to improve outcomes for cancer patients by
developing intuitive software tools to better collect and learn
from real world data," said David
Lindsay, Oncora co-founder and chief executive officer. "We
look forward to partnering with Varian to develop and deploy
innovative new tools in the fight against cancer."
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 9,200 employees across 70 countries keep
the patient and our clinical partners at the center of our thinking
as we power new victories in cancer care. Because, for cancer
patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
About Oncora Medical, Inc.
Oncora Medical, Inc., a
privately held software company in Philadelphia, PA, has developed a powerful
predictive analytics platform for oncology, capable of analyzing
diverse healthcare data and applying advanced machine learning
techniques to produce valuable clinical insights. Currently, Oncora
is working to improve the cancer experience (both for physicians
and their patients) with software to help design more personalized
treatment plans and generate real world data to support scientific
advancement. For more information on how Oncora is fighting cancer
with data, visit oncoramedical.com.
Press Contact
Mark
Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Oncora Medical
Alessandra Patrizio
Manager, Operations
+1 (215) 853-6903
press@oncoramedical.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-and-oncora-partner-to-accelerate-precision-medicine-in-radiation-oncology-300917662.html
SOURCE Varian